Abbvie Inc

NYSE:ABBV   4:00:00 PM EDT
-3.10 (-1.98%)
7:41:20 PM EDT: $153.80 +0.13 (+0.09%)
Products, Strategic Combinations

HBM Holdings Updates On Collaboration With Abbvie, Utrecht University For Co-Development Of HBM9022

Published: 12/09/2020 01:49 GMT
Abbvie Inc (ABBV) - On Dec 3, Abbvie Inc, Unit, Utrecht University Holding Bv and Universiteit Utrecht Entered License Agreement.
Agreement for Advancement of Development of Covid-19 Neutralizing Antibody 47d11.
Under Agreement, Abbvie to Conduct Clinical Development of Antibody, & If Successful, Will Manufacture & Commercialize Product Worldwide.